| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
MRC Retrovirus Research Laboratory, Department of Veterinary Pathology, University of Glasgow, Bearsden Road, Glasgow G61 1QH, U.K.
The human immunodeficiency virus (HIV) type 1 nef gene product was expressed as an N-terminal fusion protein with glutathione-S-transferase (GST) in the baculovirus system. The resulting nefGST fusion protein was found to be authentically myristylated at the N terminus and could be purified to homogeneity by one-step affinity chromatography on immobilized glutathione. The high affinity of nefGST for glutathione was exploited to develop an assay to identify cellular proteins capable of interacting with nef. Several such proteins were identified in extracts from the Jurkat human T cell line. The interaction between nef-binding proteins and immobilized nefGST could be specifically competed by the addition of soluble nef. Cell fractionation showed that nef-binding proteins were present in both cytosolic and membrane-associated fractions. A non-myristylated derivative failed to bind to the membrane-associated proteins but was able to bind to the cytosolic group, albeit with reduced affinity. In addition, a single protein present in both soluble and membrane-associated fractions exhibited myristylation-independent binding to nef. By analogy with other myristylated proteins such as MARCKS (myristylated alanine-rich C kinase substrate) and the Rous sarcoma virus transforming protein, src, the membrane-associated proteins that bind only to myristylated nef may represent a specific membrane target for nef. The cytosolic proteins that interact with nef may constitute soluble components of an as yet unidentified signal transduction pathway which is the target of nef action in the HIV-1-infected cell.
Received 2 February 1993;
accepted 19 March 1993.
This article has been cited by other articles:
|
|
 |
|
  A. Street, A. Macdonald, K. Crowder, and M. Harris The Hepatitis C Virus NS5A Protein Activates a Phosphoinositide 3-Kinase-dependent Survival Signaling Cascade J. Biol. Chem., March 26, 2004; 279(13): 12232 - 12241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bentham, S. Mazaleyrat, and M. Harris The di-leucine motif in the cytoplasmic tail of CD4 is not required for binding to human immunodeficiency virus type 1 Nef, but is critical for CD4 down-modulation J. Gen. Virol., October 1, 2003; 84(10): 2705 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Preusser, L. Briese, A. S. Baur, and D. Willbold Direct In Vitro Binding of Full-Length Human Immunodeficiency Virus Type 1 Nef Protein to CD4 Cytoplasmic Domain J. Virol., April 15, 2001; 75(8): 3960 - 3964. [Abstract] [Full Text]
|
|
|
|
|
|
D. R. Hodge, K. J. Dunn, G. K. Pei, M. K. Chakrabarty, G. Heidecker, J. A. Lautenberger, and K. P. Samuel Binding of c-Raf1 Kinase to a Conserved Acidic Sequence within the Carboxyl-terminal Region of the HIV-1 Nef Protein J. Biol. Chem., June 19, 1998; 273(25): 15727 - 15733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Coates, S. J. Cooke, D. A. Mann, and M. P. G. Harris Protein Kinase C-mediated Phosphorylation of HIV-I Nef in Human Cell Lines J. Biol. Chem., May 9, 1997; 272(19): 12289 - 12294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Collette, H. Dutartre, A. Benziane, F. Ramos-Morales, R. Benarous, M. Harris, and D. Olive Physical and Functional Interaction of Nef with Lck J. Biol. Chem., March 15, 1996; 271(11): 6333 - 6341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Sawai, A. S. Baur, B. M. Peterlin, J. A. Levy, and C. Cheng-Mayer A Conserved Domain and Membrane Targeting of Nef from HIV and SIV Are Required for Association with a Cellular Serine Kinase Activity J. Biol. Chem., June 23, 1995; 270(25): 15307 - 15314. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
